Skip to main content
Explore URMC

URMC Logo

URMC / Research / Research@URMC
New Technologies May Speed Flu Vaccine Testing

New Technologies May Speed Flu Vaccine Testing

The AIR™ Platform, a silicon chip and imaging system marketed by Adarza Biosystems, can detect immune responses to flu virus and vaccines alike.  With a small blood sample, doctors can confirm a suspected flu infection, see if a vaccine induces a desired immune response, or predict which strains of flu will affect people in the coming flu season.

9/12/2016
From Flu to Smallpox, URMC Clinical Trials Lead the Way to Vaccines

From Flu to Smallpox, URMC Clinical Trials Lead the Way to Vaccines

The Vaccine Research Unit at the University of Rochester Medical Center began conducting vaccine trials in the 1970s. Their work has led to the approval of new flu vaccines and the first and only vaccine to prevent cancer and continues today with studies of bird flu and norovirus. 

6/9/2016
Getting a Flu Shot? Skip the Advil, Tylenol, for Mild Discomfort

Getting a Flu Shot? Skip the Advil, Tylenol, for Mild Discomfort

Each year during flu season we check in with URMC scientist Rick Phipps to find out if his evidence-based advice holds true—and it still does: It’s best to avoid common pain relievers after a flu shot because they can dilute the power of the vaccine.

10/15/2015
Study Suggests Vaccinating Against Bird Flu Before a Possible Pandemic

Study Suggests Vaccinating Against Bird Flu Before a Possible Pandemic

A new study published in the Journal of Infectious Diseases suggests that priming the body ahead of a possible pandemic is a smart move.

11/19/2014
Research at the New York Influenza Center of Excellence Continues with New NIH Grant

Research at the New York Influenza Center of Excellence Continues with New NIH Grant

Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines. 

4/10/2014
12